← Scroll for more →
Financial Statements — SMX
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.20 | 0.75 | 2.34 | 0.17 | 0.17 | 1.40 | 4.17 |
| Total Current Assets | 12.79 | 1.75 | 4.34 | 0.37 | 0.80 | 5.07 | -- |
| Goodwill | 20.12 | 26.14 | 26.14 | 32.96 | 32.96 | -- | -- |
| Total Non-current Assets | 28.65 | 37.16 | 39.19 | 50.19 | 50.36 | 6.22 | -- |
| Total Assets | 41.44 | 38.91 | 43.53 | 50.56 | 51.16 | 11.29 | -- |
| Total Current Liabilities | 21.73 | 22.25 | 20.80 | 19.81 | 18.02 | 4.93 | -- |
| Total Non-current Liabilities | 0.38 | 0.37 | 0.34 | 0.39 | 0.89 | 4.21 | -- |
| Total Liabilities | 22.11 | 22.62 | 21.14 | 20.20 | 18.92 | 9.13 | -- |
| Retained Earnings | (251.20) | (105.66) | (82.03) | (61.63) | (50.93) | (30.02) | -- |
| Total Stockholder Equity | 19.33 | 16.29 | 22.39 | 30.36 | 32.24 | 2.16 | 7.89 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Research & Development | 1.64 | 1.69 |
| Selling, General & Admin | 18.66 | 4.85 |
| Operating Income | (23.75) | (9.26) |
| Pretax Income | (24.62) | (10.89) |
| Net Income | (24.62) | (10.69) |
| Basic EPS | (18,219.00) | -0.00 |
| Diluted EPS | (18,219.00) | -0.00 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Operating Cash Flow | (4.14) | (4.54) |
| Investing Cash Flow | (0.19) | (0.17) |
| Financing Cash Flow | 2.69 | 4.64 |
← Scroll for more columns →